Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-03-25
2008-03-25
Kim, Jennifer (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S220000
Reexamination Certificate
active
10621229
ABSTRACT:
The invention relates to the use of flumazenil in developing a drug used for the sequential administration of small quantities of flumazenil at short intervals, until a therapeutically effective quantity is administered to treat alcohol dependence.
REFERENCES:
patent: 5434156 (1995-07-01), Bjork et al.
patent: 5519017 (1996-05-01), Opitz
patent: 6455276 (2002-09-01), Le Bourdelles et al.
patent: 6740677 (2004-05-01), Xue et al.
Aguirre et al. Plasma-b-endorphin levels in chronic alcoholics, Alcohol, vol. 7, pp. 409-412, 1990.
Soderpalm et al. Benzodiazepines enhance the consumption and palatability of alcohol in the rat. Psychopharmacology, 1998, 137:215-222.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Washington, D.C., American Psychiatric Association, 1994, pp. 194-204.
Buck, K. J., Reversal of Alcohol Dependence and Tolerance by a Single Adminstration of Flumazenil, The Journal of Pharmacology and Experimental Therapeutics, 1991, vol. 257, No. 3, pp. 984-989.
File, S.E., Effects of Nitrendipine, Chlordiazepoxide, Flumazenil and Baclofen on the Increased Anxiety Resulting from Alcohol Withdrawal, Prog. Neuro-Psychopharmacol & Biol. Psychiatry, 1992, vol. 16, No. 1, pp. 87-93.
Gerra, G., Effectiveness of Flumazenil in the Treatment of Ethanol Withdrawal, Current Therapeutic Research, Jul. 1991, vol. 50, No. 1, pp. 62-66.
Nutt, D., Benzodiazepine Receptors in Alcohol Withdrawal Neuroschycopharmacology, May 1994, vol. 10, No. 35. Part 1.
Nutt, D., Flumazenil in Alcohol Withdrawal, Alcohol & Alcoholism, 1991, Suppl. 2, pp. 337-341.
Potokar, J. Flumazenil in Alcohol Withdrawal: a Double-blind Placebo-controlled Study. Alcohol & Alcoholism, 1997, vol. 32, No. 5, pp. 605-611.
Practice Management Information Corporation: International Classification of Diseases, 9thRevision, Clinical Modification, Sixth Edition (ICD-9-CM), 2004, selected pages.
Bell, E.C., et al., “Response to Flumazenil in the Late Luteal Phase and Follicular Phase of the Menstrual Cycle in Healthy Control Females,”Psychopharmacology, vol. 172, pp. 248-254 (2004).
Berezhnoy, D., et al., “Conformational Changes at Benzodiazepine Binding Sites of GABAAReceptors Detected With a Novel Technique,”J. Neurochemistry, vol. 92, pp. 859-866 (2005).
Betz, C., et al., “Could a Common Biochemical Mechanism Underlie Addictions?,”J. Clin. Pharm Ther., vol. 25, No. 1, pp. 11-20 (2000) (Abstract Only).
Biggio, G., et al., “Molecular Mechanisms of Tolerance to and Withdrawal of GABA(A) Receptor Modulators,”Eur. Neuropsychopharmacol., vol. 13, No. 6, pp. 411-423 (2003).
Boehm, S.L., et al., “γ-Aminobutyric Acid A Receptor Subunit Mutant Mice : New Perspectives on Alcohol Actions,”Biochemical Pharmacology, vol 68, pp. 1581-1602 (2004).
Buckley, S.T., et al., “GABAAReceptor β Subunit mRNA Expression in the Human Alcoholic Brain,”Neurochemistry International, vol. 45, pp. 1011-1020 (2004).
Casasola, C., et al., “Hyperexcitability Induced by GABA Withdrawal Facilitates Hippocampal Long-term Potentiation,”Neuroscience, vol. 126, pp. 163-171 (2004).
Clark, M., Sensitivity of the Rat Hippocampal GABAAReceptor α4 Subunit to Electroshock Seizures,Neuroscience Letters, vol. 250, pp. 17-20 (1998).
Criswell, H.E., et al., “Effect of Zolpidem on Gamma-aminobutyric Acid (GABA)- Induced Inhibition Predicts the Interaction of Ethanol with GABA on Individual Neurons in Several Rat Brain Regions”J. Pharmacol. Exp. Therap., vol. 273, No. 1, pp. 526-536 (1995) (Abstract Only).
Davies, M., The Role of GABAAReceptors in Mediating the Effects of Alcohol in the Central Nervous System,J. Psychiatry Neurosci., vol. 28, No. 4, pp. 263-274 (2003).
Devaud L. L, et al., “Bidirectional Alterations of GABA(A) Receptor Subunit Peptide Levels in Rat Cortex During Chronic Ethanol Consumption and Withdrawal,”J. Neurochem., vol. 69, No. 1, pp. 126-130 (1997), Abstract only.
Devaud L.L, et al., “Chronic Ethanol Consumption Differentially Alters the Express of Gamma-aminobutyric acidA. . . Chain Reaction Analysis,”Mol. Pharmacol., vol. 48, No. 5, pp. 861-868 (1995), Abstract only.
Devaud L.L, et al., “Influence of Gender on Chronic Ethanol-Induced Alterations in GABAAReceptors in Rats,”Brain Res., vol. 796, Nos. 1&2, pp. 222-230 (1998), Abstract only.
Devaud L.L, et al., “Sensitization of Gamma-Aminobutyric acidAReceptors to Neuroactive Steroids in Rats During Ethanol Withdrawal,”J. Pharmacol. Exp. Ther., vol. 278, No. 2, pp. 510-517 (1996), Abstract only.
DuBois, D.W., et al., “Binge Ethanol Exposure Delays Development of GABAergic Miniature Postsynaptic Currents in Septal Neurons,”Developmental Brain Research, vol. 152, pp. 199-212 (2004).
File, S.E., et al, “Effects of Nitrendipine, Chlordiazepoxide, Flumazeil and Baclofen on the Increased Anxiety Resulting from Alcohol Withdrawal,”Prog. Neuropsychopharmacol. Biol. Psychiatry, vol. 16, No. 1, pp. 87-93 (1992) (Abstract Only).
File, S.E., et al., “Benzodiazepine Withdrawal: Behavioural Pharmacology and Neurochemical Changes.”Biochem. Soc. Symp., vol. 59, pp. 97-106 (1993) (Abstract Only).
File, S.E., et al., “Flumazenil but not Nitrendipine Reverses the Increased Anxiety During Ethanol Withdrawal in the Rat,”Psychopharmacology, vol. 98, No. 2, pp. 262-264 (1989), Abstract only.
Finn, D.A., et al., “Differential Change in Neuroactive Steroid Sensitivity During Ethanol Withdrawal,”J. Pharmacology and Experimental Therapeutics, vol. 292, No. 1, pp. 394-405 (2000).
Follesa, P., et al., Modulation of GABAAreceptor Gene Expression by Allogpregnanolone and Ethanol,Euro. J. Phamacology, vol. 500, pp. 413-425 (2004).
Follesa, P., et al., γ-Hydroxybutyric Acid and Diazepam Antagonize a Rapid Increase in GABAAReceptors α4 Subunit mRNA Abundance Induced by Ethanol Withdrawal in Cerebellar Granule Cells,Molecular Pharmacology, vol. 63, No. 4, pp. 896-907 (2003).
Green, K.L, et al., The Influence of Menstrual Cycle Phase on Sensitivity to Ethanol-Like Discriminative Stimulus Effects of GABAA-Positive Modulators,Pharmacology Biochemisty and Behavior, vol. 64, No. 2, pp. 379-383 (1999).
Grobin, A.C., et al., “The role of GABA(A) Receptors in the Acute and Chronic Effects of Ethanol,”Psychopharmacology(Berl.), vol. 139, Nos. 1-2, pp. 2-19 (1998) (Abstract Only).
Grobin, A.C., et al., “Chronic Ethanol Administration Alters Immunoreactivity for GABAAReceptor Subunits in Rat Cortex in a Region-Specific Manner,”Alcholosim, vol. 24, No. 8, pp. 1137-1144 (2000), Abstract only.
Hanchar, H.J., et al, “Alcohol Effects on γ-aminobutyric Acid Type A Receptors: Are Extrasynaptic Receptors the Answer?,”Life Sciences, vol. 76, pp. 1-8 (2004).
Hirani, K., et al., “Evaluation of GABAergic Neuroactive Steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a Neurobiological Substrate for the Anti-Anxiety Effect of Ethanol in Rats,”Psychopharmacology(Berl.), (Epub ahead of print) (2005) (Abstract Only).
Holtman, Jr., J.R., et al., “Modification of Morphine Analgesia and Tolerance by Flumazenil in Male and Female Rats,”Euro. J. Pharmacology, vol. 470, pp. 149-156 (2003).
Janak, P.H., et al., “The Reinforcing Effects of Ethanol are Altered by the Endogenous Neurosteroid, Allpregnanolone,”Alcohol Clin. Exp. Res., vol. 22, No. 5, pp. 1106-1112 (1998) (Abstract Only).
Janis, G.C., et al., Effects of Chronic Ethanol Consumption and Withdrawal on the Neuroactive Steroid 3alpha-hydroxy-5alpha-pregnan-20-one in Male and Female Rates,Alcohol Clin. Exp. Res., vol. 22, No. 9, pp. 2055-2061 (1998) (Abstract Only).
June, H.L., et al., “Ethanol Self-Administration in Freely Feeding and Drinking Rats; Effects of Ro15-4513 alone, and in Combination with Ro15-1788 (Flumazenil),”Psychopharmacology(Berl.), vol. 115, No. 3, pp. 332-339
Hythiam, Inc.
Kilpatrick & Stockton LLP
Kim Jennifer
LandOfFree
Flumazenil for the treatment of alcohol dependency does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Flumazenil for the treatment of alcohol dependency, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flumazenil for the treatment of alcohol dependency will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3933040